James T Wu

Summary

Affiliation: Texas Medical Center
Country: USA

Publications

  1. ncbi request reprint The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy
    James T Wu
    Department of Surgery, SUNY Downstate Medical Center, Brooklyn, New York, USA
    J Surg Res 123:158-69. 2005
  2. pmc Ghrelin: integrative neuroendocrine peptide in health and disease
    James T Wu
    Department of Surgery, SUNY Downstate Medical Center, Brooklyn, NY 11203, USA
    Ann Surg 239:464-74. 2004
  3. ncbi request reprint Cell-free DNA: measurement in various carcinomas and establishment of normal reference range
    Tsu Lan Wu
    Department of Pathology, Chang Gung Memorial Hospital, Taipei, Taiwan
    Clin Chim Acta 321:77-87. 2002
  4. ncbi request reprint C-erbB2 oncoprotein and its soluble ectodomain: a new potential tumor marker for prognosis early detection and monitoring patients undergoing Herceptin treatment
    James T Wu
    Department of Pathology and ARUP, University of Utah Health Sciences Center, Salt Lake City, UT 84132, USA
    Clin Chim Acta 322:11-9. 2002
  5. ncbi request reprint Linking inflammation and atherogenesis: Soluble markers identified for the detection of risk factors and for early risk assessment
    James T Wu
    ARUP Laboratories and Cardiovascular Genetics, Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah 84108, USA
    Clin Chim Acta 366:74-80. 2006

Collaborators

  • John G Kral
  • Tsu Lan Wu
  • Chien Feng Sun
  • Diana Zhang
  • Ju Hsin Chia
  • Kuo hien Tsao

Detail Information

Publications5

  1. ncbi request reprint The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy
    James T Wu
    Department of Surgery, SUNY Downstate Medical Center, Brooklyn, New York, USA
    J Surg Res 123:158-69. 2005
    ..In this review, we discuss the regulatory mechanisms and physiological significance of NF-kappaB activation, and highlight recent advances in the development of NF-kappaB as an integral mediator of mammary carcinogenesis...
  2. pmc Ghrelin: integrative neuroendocrine peptide in health and disease
    James T Wu
    Department of Surgery, SUNY Downstate Medical Center, Brooklyn, NY 11203, USA
    Ann Surg 239:464-74. 2004
    ..Newly discovered biologic roles of ghrelin imply that it may have other important physiological functions as well. This is a review of recent clinically relevant, yet less well-known, physiologic actions of ghrelin...
  3. ncbi request reprint Cell-free DNA: measurement in various carcinomas and establishment of normal reference range
    Tsu Lan Wu
    Department of Pathology, Chang Gung Memorial Hospital, Taipei, Taiwan
    Clin Chim Acta 321:77-87. 2002
    ..Numerous reports in the literature have pointed out that cell-free DNA in plasma or serum has the clinical potential to be a more specific tumor marker for the diagnosis and prognosis, as well as the early detection, of cancer...
  4. ncbi request reprint C-erbB2 oncoprotein and its soluble ectodomain: a new potential tumor marker for prognosis early detection and monitoring patients undergoing Herceptin treatment
    James T Wu
    Department of Pathology and ARUP, University of Utah Health Sciences Center, Salt Lake City, UT 84132, USA
    Clin Chim Acta 322:11-9. 2002
    ..Activation of p185 appears to be an early event in tumorigenesis for some cancers. It is possible that the ectodomain could be used as an early tumor marker detecting benign disease...
  5. ncbi request reprint Linking inflammation and atherogenesis: Soluble markers identified for the detection of risk factors and for early risk assessment
    James T Wu
    ARUP Laboratories and Cardiovascular Genetics, Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah 84108, USA
    Clin Chim Acta 366:74-80. 2006
    ..These soluble markers should also be useful for monitoring the effectiveness of intervention and for the identification of therapeutic targets...